Showing results (961-970 of 1,007) with videos related to

Sort By:
Pageof 101
Molecular Cancer Therapeutics|October 18, 2019
On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid TumorsFranck Morschhauser, Jean-Pascal Machiels, Gilles Salles, et al.
Breast Cancer Research and Treatment|March 22, 2017
A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancerJosé Baselga, Serafin M Morales, Ahmad Awada, et al.
Breast Cancer Research and Treatment|July 6, 2012
A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancerMartin Schuler, Ahmad Awada, Philipp Harter, et al.
Frontiers in Cardiovascular Medicine|April 25, 2025
Pulmonary vein isolation durability with fluoroscopy or 3D mapping-guided radiofrequency balloon ablation: a mandated remap studyAlexandre Almorad, Alvise Del Monte, Domenico Giovanni Della Rocca, et al.
Blood Advances|February 3, 2019
Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasiaHassan Awada, Yasunobu Nagata, Abhinav Goyal, et al.
Breast Cancer Research and Treatment|June 15, 2017
Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trialJavier Cortés, Hope S Rugo, Ahmad Awada, et al.
Nature Communications|November 26, 2025
Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 studyAndreas Papagiannis, Samira Majjaj, Francois P Duhoux, et al.
ESMO Open|April 10, 2026
Efficacy and safety of regorafenib in patients with advanced pretreated melanoma: results of the RegoMel phase II clinical trialI Dirven, C Bertels, Y Moreels, et al.
The Lancet. Oncology|October 21, 2015
Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trialEdith A Perez, Ahmad Awada, Joyce O'Shaughnessy, et al.
Zoonoses and Public Health|April 6, 2013
Review of influenza A virus in swine worldwide: a call for increased surveillance and researchA Vincent, L Awada, I Brown, et al.
Pageof 101